₹1148.30▼₹2.55(-0.22%)
EOD close · 3 Jul 2026
mid rallyneutral -9
Above 50- and 200-day MAs with +17.2% over 3 months — established uptrend.
52W low ₹830.0052W high ₹1193.30
Now at 88% of its 52-week range
Long-term returns
1Y
+12.3%
3Y
+101.9%
Phase indicator
mid rally-3.8% from 52w high
Above 50- and 200-day MAs with +17.2% over 3 months — established uptrend.
1M
+11.7%
3M
+17.2%
1Y
+12.3%
Delivery conviction
neutralscore -9
Delivery vs 20-day avg0.75x
Lifetime story
Alivus Life Sciences is up 211.2% from its lifetime low of ₹369.00 on 22 Feb 2023. ₹10,000 invested then would be worth ₹31,119 today (40.2% CAGR over 3.4 years). Lifetime high of ₹1335.00 was set on 16 Sept 2024 (currently -14.0% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
49% cheaper than industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 25.16 | 0.00 |
| P/B | 4.27 | — |
| Price / Cash flowsubs material | 22.19 | 0.00 |
| Dividend yield | 0.43% | 0.43% |
| Book value / share | 271.48 ₹ | — |
| EPS (TTM)subs material | 45.99 ₹ | 0.00 ₹ |
Market cap
₹14.2K Cr
52W high
₹1193.30
2 Jul 2026
52W low
₹830.00
22 Jan 2026
Returns ladder
1W
+4.5%
1M
+11.7%
3M
+17.2%
6M
+26.7%
YTD
+26.1%
1Y
+12.3%
3Y
+101.9%
5Y
—
10Y
—
Since listing
+54.6%